Bayer/Monsanto Propose $7.25 Billion Roundup Cancer Settlement
In February 2026, Bayer announced a $7.25 billion class-action settlement plan from its subsidiary Monsanto that would resolve current and future cancer claims related to the use of Roundup weed killer. If the settlement plan is accepted in court, it would award payments to lawsuit participants diagnosed with Non-Hodgkin’s Lymphoma—alive or deceased—for up to 21 […]
Bayer/Monsanto Propose $7.25 Billion Roundup Cancer Settlement Read More »